Nutanix Director Awarded Routine Stock Grant (RSUs)
Nutanix, Inc.
Subscribe to track NTNX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Nutanix Director Awarded Routine Stock Grant
Company: Nutanix, Inc. (NTNX) Form: 4 | Filed: 2025/12/16 Significance: Low
Insider: BRANDT ERIC Title: Not Specified | Relationship: Director
Transaction: • Type: Grant • Shares: 4,588 • Price: $0.00 • Value: $0 • Owned After: 6,698
Key Insight: This is a routine grant of Restricted Stock Units (RSUs) to a director as part of their compensation package. The shares vest over one year, indicating a standard long-term incentive.
Market Context: The transaction has a $0 value and represents a negligible fraction of the company's $17.85B market cap. This is a non-market event with no immediate trading implications.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Nutanix, Inc. (NTNX)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director received a routine, pre-scheduled grant of Restricted Stock Units (RSUs) as part of their compensation, with no cash value exchanged.
- Market Impact: Neutral. This is a standard corporate governance event and does not signal a change in insider sentiment.
Company Information
| Field | Value |
|---|---|
| Company | Nutanix, Inc. |
| Ticker Symbol | NTNX |
| CIK | 0001618732 |
| Industry | SERVICES-PREPACKAGED SOFTWARE [7372] |
Insider Information
| Field | Value |
|---|---|
| Name | BRANDT ERIC |
| CIK | 0001190639 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-12 |
| Transaction Code | A (Grant) |
| Security Type | Class A Common Stock |
| Shares Involved | 4,588 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 6,698 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 4,588 |
| % of Shares Outstanding | Not Calculable (Data Unavailable) |
| Post-Transaction Ownership | 6,698 shares |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction has a reported value of $0, making it immaterial against Nutanix's $17.85 billion market capitalization.
- Dilution Impact: As shares outstanding data is not available, a precise dilution percentage cannot be calculated. However, a grant of this size is typical for director compensation in a large-cap tech company and is expected to have a negligible dilutive effect on existing shareholders.
- Transaction Significance: This is a non-cash award (Code 'A') and not an open market transaction. Its significance is low, serving as a standard incentive for the director rather than a market-based investment decision.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: RSU grants are a form of compensation and do not reflect an insider's discretionary decision to buy or sell shares on the open market. They are not typically interpreted as a bullish or bearish signal by the market.
Volume & Sentiment
- Expected Volume Impact: None. This is not an open-market transaction and will not directly impact trading volume.
- Sentiment Indicator: Neutral. The market views such grants as a routine cost of business for retaining board talent.
Additional Context
Transaction Notes
- Special Circumstances: The filing's footnotes clarify these are Restricted Stock Units (RSUs) that vest in full on the earlier of the next annual shareholder meeting or the one-year anniversary of the grant date, contingent on continued service. This is a standard vesting schedule for director compensation.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
